{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:58:25Z","timestamp":1781171905469,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lansea.2026.100768","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:56:56Z","timestamp":1777607816000},"page":"100768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A decision-support tool for management of advanced epithelial ovarian cancer in a single centre in India (CT PAUSE Nomogram): a prospective Study (2022\u20132024)"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-281X","authenticated-orcid":false,"given":"Angelin Grace","family":"Jeslin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobiga","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Hiriyanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Ninan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goldwin Helan","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0858-2995","authenticated-orcid":false,"given":"Vinotha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kripa M.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Joel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reka","family":"Karuppusami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-375X","authenticated-orcid":false,"given":"Anuradha","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2026.100768_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2278-330X.187575","article-title":"Gynecological cancers: a summary of published Indian data","volume":"5","author":"Maheshwari","year":"2016","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib2","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lansea.2026.100768_bib3","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0090-8258(03)00342-1","article-title":"Future directions in the surgical management of ovarian cancer","volume":"90","author":"Berman","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib7","article-title":"Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery","volume":"9","author":"Bryant","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lansea.2026.100768_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12905-024-02977-5","article-title":"The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis","volume":"24","author":"Chase","year":"2024","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.lansea.2026.100768_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100586","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials","volume":"7","author":"Filis","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.lansea.2026.100768_bib10","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.3390\/cancers15245827","article-title":"Imaging of peritoneal carcinomatosis in advanced ovarian cancer: CT, MRI, Radiomic features and Resectability criteria","volume":"15","author":"Miceli","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.lansea.2026.100768_bib11","doi-asserted-by":"crossref","first-page":"S689","DOI":"10.1016\/j.jacr.2025.08.033","article-title":"ACR appropriateness criteria\u00ae staging and follow-up of ovarian cancer: 2025 update","volume":"22","author":"Stein","year":"2025","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.lansea.2026.100768_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2214\/AJR.23.29096","article-title":"Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: impact on documentation of disease sites and physician satisfaction","volume":"221","author":"Andrieu","year":"2023","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.lansea.2026.100768_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jjco\/hyaa145","article-title":"Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602","volume":"51","author":"Onda","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib14","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.250116","article-title":"Imaging in advanced epithelial ovarian cancer: assessment of peritoneal spread","volume":"318","author":"Nougaret","year":"2026","journal-title":"Radiology"},{"key":"10.1016\/j.lansea.2026.100768_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.lansea.2026.100768_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2020.05.041","article-title":"A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center team ovary initiative","volume":"158","author":"Straubhar","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0039-1698480","article-title":"Management driven structured reporting in ovarian cancer","volume":"3","author":"Chandramohan","year":"2020","journal-title":"J Gastrointest Abdom Radiol"},{"key":"10.1016\/j.lansea.2026.100768_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.diii.2022.05.003","article-title":"The BUMPy road of peritoneal metastases in ovarian cancer","volume":"103","author":"Nougaret","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.lansea.2026.100768_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.crad.2017.07.005","article-title":"\u2018PAUSE\u2019: a method for communicating radiological extent of peritoneal malignancy","volume":"72","author":"Chandramohan","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.lansea.2026.100768_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13244-021-01118-y","article-title":"Communicating imaging findings in peritoneal mesothelioma: the impact of \u2018PAUSE\u2019 on surgical decision-making","volume":"12","author":"Chandramohan","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.lansea.2026.100768_bib23","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s00330-024-11124-5","article-title":"Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM","volume":"35","author":"Vandecaveye","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.lansea.2026.100768_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.lansea.2026.100768_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bjs5.50256","article-title":"Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting","volume":"4","author":"Brandl","year":"2020","journal-title":"BJS Open"},{"key":"10.1016\/j.lansea.2026.100768_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5180895","article-title":"Colorectal peritoneal metastases: a systematic review of current and emerging trends in clinical and translational research","volume":"2019","author":"Koumpa","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.lansea.2026.100768_bib27","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3802\/jgo.2018.29.e47","article-title":"Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study","volume":"29","author":"Elzarkaa","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.20836","article-title":"Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"103","author":"Yan","year":"2005","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1016\/j.lansea.2026.100768_bib29","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s002800051093","article-title":"Successful management of microscopic residual disease in large bowel cancer","volume":"43","author":"Sugarbaker","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lansea.2026.100768_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.lansea.2026.100768_bib31","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.2147\/CMAR.S249540","article-title":"Further understanding of high-grade serous ovarian carcinogenesis: potential therapeutic targets","volume":"12","author":"Voutsadakis","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.lansea.2026.100768_bib32","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2024.07.044","article-title":"Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation","volume":"232","author":"Jochum","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lansea.2026.100768_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib34","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian carcinomatosis: how the radiologist can help plan the surgical approach","volume":"32","author":"Nougaret","year":"2012","journal-title":"Radiographics"},{"key":"10.1016\/j.lansea.2026.100768_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3348\/kjr.2023.0840","article-title":"Imaging evaluation of peritoneal metastasis: current and promising techniques","volume":"25","author":"Fu","year":"2024","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.lansea.2026.100768_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116614","article-title":"MRI in advanced ovarian cancer: Multicentre MISSION trial","volume":"238","author":"Berardi","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib37","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures","volume":"22","author":"Low","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","article-title":"Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis","volume":"122","author":"Laghi","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.lansea.2026.100768_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2007.10.001","article-title":"The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer","volume":"108","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/ijgc-2019-000778","article-title":"Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer","volume":"30","author":"Muallem","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib41","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib42","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ejso.2021.03.233","article-title":"Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer - a systematic review","volume":"47","author":"Engbersen","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/IGC.0000000000000069","article-title":"Impact of ascites on the perioperative course of patients with advanced ovarian cancer undergoing extensive cytoreduction: results of a study on 119 patients","volume":"24","author":"Feldheiser","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.lansea.2026.100768_bib44","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jog.14682","article-title":"Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer","volume":"47","author":"Quan","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.lansea.2026.100768_bib45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.lansea.2026.100768_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf098","article-title":"Peritoneal surface malignancy: performing complete cytoreduction in occult peritoneal spaces is challenging","volume":"112","author":"Glehen","year":"2025","journal-title":"Br J Surg"},{"key":"10.1016\/j.lansea.2026.100768_bib47","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","article-title":"Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis","volume":"30","author":"van \u2019t Sant","year":"2020","journal-title":"Eur Radiol"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:13:53Z","timestamp":1781169233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368226000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S2772368226000533"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100768","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decision-support tool for management of advanced epithelial ovarian cancer in a single centre in India (CT PAUSE Nomogram): a prospective Study (2022\u20132024)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100768"}}